Fanny Krebs

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


12 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
2024
 
Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers
Pradervand S., Freundler N., Gosztonyi B., Roncoroni L., Achermann R., Schwenk T., de Fraipont G., Garessus J., Haefliger S., Leichtle A.B. et al., 2024/12. ESMO Real World Data and Digital Oncology, 6 p. 100075.
[DOI][serval:BIB_6614336939D6]
Methylation-Based Characterization of a New IDH2 Mutation in Sinonasal Undifferentiated Carcinoma.
Burgermeister S., Stoykova S., Krebs F.S., Zoete V., Mbefo M., Egervari K., Reinhard A., Bisig B., Hewer E., 2024/06/13. International journal of molecular sciences, 25 (12). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FC381A964AFC]
Herpes simplex encephalitis due to a mutation in an E3 ubiquitin ligase.
Bibert S., Quinodoz M., Perriot S., Krebs F.S., Jan M., Malta R.C., Collinet E., Canales M., Mathias A., Faignart N. et al., 2024/05/10. Nature communications, 15 (1) p. 3969. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_63AF76DC891D]
2023
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma.
Krebs F.S., Moura B., Missiaglia E., Aedo-Lopez V., Michielin O., Tsantoulis P., Bisig B., Trimech M., Zoete V., Homicsko K., 2023/02/24. International journal of molecular sciences, 24 (5) p. 4520. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E3A48A3138B7]
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Álvarez-Prado Á.F., Maas R.R., Soukup K., Klemm F., Kornete M., Krebs F.S., Zoete V., Berezowska S., Brouland J.P., Hottinger A.F. et al., 2023/01/17. Cell reports. Medicine, 4 (1) p. 100900. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B718E4D7ABEC]
2022
 
Structure-based prediction of BRAF mutation classes using machine-learning approaches.
Krebs F.S., Britschgi C., Pradervand S., Achermann R., Tsantoulis P., Haefliger S., Wicki A., Michielin O., Zoete V., 2022/07/22. Scientific reports, 12 (1) p. 12528. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5CB3AA02B4B8]
2021
 
α,α-Difluorophosphonohydroxamic Acid Derivatives among the Best Antibacterial Fosmidomycin Analogues
Dreneau Aurore, Krebs Fanny S., Munier Mathilde, Ngov Chheng, Tritsch Denis, Lièvremont Didier, Rohmer Michel, Grosdemange-Billiard Catherine, 2021/08/23. Molecules, 26 (16) p. 5111.
[DOI][WoS][Pmid][serval:BIB_F813F4CA450A]
Swiss-PO: a new tool to analyze the impact of mutations on protein three-dimensional structures for precision oncology.
Krebs F.S., Zoete V., Trottet M., Pouchon T., Bovigny C., Michielin O., 2021/03/18. NPJ precision oncology, 5 (1) p. 19. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A929D45E3DA0]
2020
Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology.
Krebs F.S., Gérard C., Wicky A., Aedo-Lopez V., Missiaglia E., Bisig B., Trimech M., Michielin O., Homicsko K., Zoete V., 2020/10/28. International journal of molecular sciences, 21 (21) pp. E8021. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_44F221AEB60A]
2019
 
The Romand Network of Oncology: bridging the gap of personalised oncology
Michielin O., Tsantoulis P., Homicsko K., Christinat Y., De Leval L., Bisig B., Missiaglia E., Zoete V., Krebs F., Fortin A. et al., 2019/10/18. Swiss Medical Weekly.
[serval:BIB_2A3947B3BCE2]
 
A computational study of the molecular basis of antibiotic resistance in a DXR mutant.
Krebs F.S., Esque J., Stote R.H., 2019/10. Journal of computer-aided molecular design, 33 (10) pp. 927-940. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_47BDAAB4C30F]
2017
 
Synthesis and biological evaluation of phosphate isosters of fosmidomycin and analogs as inhibitors of Escherichia coli and Mycobacterium smegmatis 1-deoxyxylulose 5-phosphate reductoisomerases.
Munier M., Tritsch D., Krebs F., Esque J., Hemmerlin A., Rohmer M., Stote R.H., Grosdemange-Billiard C., 2017/01/15. Bioorganic & medicinal chemistry, 25 (2) pp. 684-689. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D7A1B4F80190]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University